PresentationI would now like to turn the conference over to Bernie Hertel, Head of Investor Relations. Please go ahead.Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to Skye Biosciences conference call to discuss Phase IIa top line clinical trial results.Bernie Hertel Good morning. Before we begin, I'd like to caution that comments made during this conference call will contain forward-looking statements under the safe harbor provisions of the U.S. Private Sec ...